Minnesota investigates Sanofi for drug pricing

Alex Wilts

06 March 2017

Credit: Wikipedia/Sanofi de

The state of Minnesota is investigating pharmaceutical company Sanofi for its pricing and trading practices for two diabetes treatment drugs, according to a securities filing last week.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Alex Wilts

View full biography

Author | Editor, GCR USA

[email protected]

Unlock unlimited access to all Global Competition Review content